Poseida Therapeutics (STU:2RZ) Beginning Cash Position : €40.91 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Poseida Therapeutics Beginning Cash Position?

Poseida Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was €40.91 Mil.

Poseida Therapeutics's quarterly Beginning Cash Position declined from Sep. 2023 (€46.77 Mil) to Dec. 2023 (€23.39 Mil) but then increased from Dec. 2023 (€23.39 Mil) to Mar. 2024 (€40.91 Mil).

Poseida Therapeutics's annual Beginning Cash Position increased from Dec. 2021 (€74.31 Mil) to Dec. 2022 (€194.77 Mil) but then declined from Dec. 2022 (€194.77 Mil) to Dec. 2023 (€74.62 Mil).

Poseida Therapeutics Beginning Cash Position Historical Data

The historical data trend for Poseida Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poseida Therapeutics Beginning Cash Position Chart

Poseida Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

27.36

72.16

74.31

194.77

74.62

Poseida Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															76.01	37.05	46.77	23.39	40.91

Poseida Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Poseida Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Poseida Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Poseida Therapeutics (STU:2RZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poseida Therapeutics Inc (STU:2RZ) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

PSTX:USA

Address

9390 Towne Centre Drive, Suite 200, San Diego, CA, USA, 92121

Website

https://www.poseida.com

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Poseida Therapeutics (STU:2RZ) Headlines

No Headlines